Oramed Pharmaceuticals
ORMP
#9104
Rank
NZ$0.15 B
Marketcap
$3.75
Share price
-2.78%
Change (1 day)
-13.53%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): NZ$39.85 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of NZ$12.73 Million, an increase over its 2022 earnings that were of -NZ$65.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$39.85 M213.1%
2023 NZ$12.73 M-119.45%
2022 -NZ$65.45 Million39.17%
2021 -NZ$47.03 Million73.93%
2020 -NZ$27.04 Million18.53%
2019 -NZ$22.81 Million-16.62%
2018 -NZ$27.36 Million38.32%
2017 -NZ$19.78 Million12.51%
2016 -NZ$17.58 Million25.01%
2015 -NZ$14.07 Million18.18%
2014 -NZ$11.9 Million39.72%
2013 -NZ$8.52 Million46.4%
2012 -NZ$5.82 Million128.32%
2011 -NZ$2.55 Million-51.47%
2010 -NZ$5.25 Million35.21%
2009 -NZ$3.89 Million
2007 -NZ$6.11 Million607.04%
2006 -NZ$0.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.91 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.84 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
NZ$14.19 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$17.35 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-NZ$0.36 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA